Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database.

Journal: The British journal of ophthalmology
Published Date:

Abstract

AIM: To evaluate the impact of fluid volume fluctuations quantified with artificial intelligence in optical coherence tomography scans during the maintenance phase and visual outcomes at 12 and 24 months in a real-world, multicentre, national cohort of treatment-naïve neovascular age-related macular degeneration (nAMD) eyes.

Authors

  • Ruben Martin-Pinardel
    Fundacio Clinic per la Recerca Biomedica, Barcelona, Spain.
  • Jordi Izquierdo-Serra
    School of Medicine, University of Barcelona, Barcelona, Spain.
  • Carolina Bernal-Morales
    Institut Clinic d'Oftalmologia (ICOF) Hospital Clinic, Barcelona, Spain; Institut de Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Sandro De Zanet
    RetinAI Medical AG, Bern, Switzerland.
  • Gonzaga Garay-Aramburu
    Ophthalmology, OSI Bilbao-Basurto, Bilbao, País Vasco, Spain.
  • Martin Puzo
    Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Aragón, Spain.
  • Carolina Arruabarrena
    Department of Ophthalmology, Retina Unit, University Hospital "Príncipe de Asturias", 28805, Madrid, Spain.
  • Laura Sararols
    Ophthalmology, Fundació Privada Hospital Asil Granollers, Granollers, Catalunya, Spain.
  • Maximino Abraldes
    Ophthalmology, Hospital Universitario de Conxo, Santiago de Compostela, Spain.
  • Laura Broc
    Hospital Universitari Germans Trias i Pujol, Badalona, Catalunya, Spain.
  • Jose Juan Escobar-Barranco
    Ophthalmology, Hospital Dos de Maig, Barcelona, Spain.
  • Marta Figueroa
    Department of Ophthalmology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Miguel Angel Zapata
  • José M Ruiz-Moreno
    Ophthalmology, Castilla-La Mancha University, Albacete, Spain.
  • Alba Parrado-Carrillo
    Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
  • Aina Moll-Udina
    Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
  • Socorro Alforja
    Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
  • Marc Figueras-Roca
    Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
  • Laia Gómez-Baldó
    Medical Department, Novartis Farmacéutica SA, Barcelona, Spain.
  • Carlos Ciller
    Research, RetinAI Medical AG, Bern, Switzerland.
  • Stefanos Apostolopoulos
    RetinAI Medical AG, Bern, Switzerland.
  • Anastasiia Mishchuk
    RetinAI US Inc, Boston, MA, USA.
  • Ricardo P Casaroli-Marano
    School of Medicine, University of Barcelona, Barcelona, Spain.
  • Javier Zarranz-Ventura
    Institut Clínic d'Oftalmologia, Hospital Clínic de Barcelona, Barcelona, Spain.

Keywords

No keywords available for this article.